Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Dixit, US
Anirudha Dixit, Amherst, MA US
| Patent application number | Description | Published |
|---|---|---|
| 20110271403 | Metal Resistant Plants, and Methods of Manufacture Thereof - Disclosed herein is a transgenic plant transformed with an isolated nucleic acid comprising a plant arsenite-inducible RNA-associated protein coding sequence operatively linked to a plant-expressible transcription regulatory sequence, wherein the plant arsenite-inducible RNA-associated protein (AIRAP) coding sequence encodes a polypeptide that is at least 95% identical to a polypeptide sequence of SEQ ID NO:8, SEQ ID NO:9, SEQ ID NO:10, SEQ ID NO:11, SEQ ID NO:12, SEQ ID NO:13, or SEQ ID NO:14, wherein the plant arsenite-inducible RNA-associated protein coding sequence encodes a polypeptide that confers resistance to an environmental stress, wherein greater than or equal to about 25% of transgenic plants are resistant to an environmental stress, and wherein the environmental stress inhibits the growth of wild type plants. | 11-03-2011 |
Bharat Dixit, Hingham, MA US
| Patent application number | Description | Published |
|---|---|---|
| 20110070292 | Methods For The Preparation Of Liposomes - Provided herein are methods for preparing liposomes and uses thereof. In certain embodiments, liposomes are prepared without using heat, organic solvents, proteins, and/or inorganic salts in the process. In certain embodiments, the liposomal preparation contains one or more active agents. In certain embodiments, the liposomal preparations are used in the treatment of diseases or disorders. | 03-24-2011 |
| 20110070294 | Methods for the Administration of Drugs Using Liposomes - Provided herein are methods for the administration of drugs using liposomes. In particular, provided herein is the use of liposomes as diluents for lyophilized or liquid drugs to deliver the drug safely, reduce the toxicity of the drug or the excipients used to solubilize or stabilize the drug. | 03-24-2011 |
Jignesh Dixit, Schaumburg, IL US
| Patent application number | Description | Published |
|---|---|---|
| 20110059749 | METHODS AND APPARATUS FOR SESSION CONTROL IN A NETWORKED LOCATIONING SYSTEM - A session control method includes establishing a locationing session between a mobile device and a remotely located server over a network, sending information related to the geographical location of the mobile device to the remotely located server after establishing the locationing session, and providing two or more notifications via the mobile device, at predetermined intervals or in response to an event, that the locationing session is active. The user may then validate or invalidate the active session, thereby providing greater control of such information. Additional configuration options are provided to the user in order to control the nature and distribution of such locationing data. | 03-10-2011 |
| 20110207469 | METHODS AND APPARATUS FOR EXTENDED GENERIC MESSAGING IN A NETWORKED GEOLOCATION SYSTEM - Generic messaging and protocols are provided for handset-to-handset communications in accordance with, for example, the Secure User Plane Location (SUPL) protocol. A mobile device initiates a geolocation-related session with a second mobile device by sending a message, including a payload, to a server (e.g., an H-SLP server) over a network. A data connection is the established between the second mobile device and the server in response to the message. A message, including the payload, is then sent to the second mobile device. The payload may include geolocation (e.g., GPS) information, such that two mobile devices may collaboratively share information regarding the other's geographical location. | 08-25-2011 |
Kashyap Dixit, State College, PA US
| Patent application number | Description | Published |
|---|---|---|
| 20120072257 | Optimizing Facility Utilization For Service Delivery - A processor identifies a first demand type, which includes a first set of demand requirements, and also identifies a second demand type, which includes a second set of demand requirements. Next, the processor retrieves a demand compatibility rule, which specifies a compatibility between the first set of demand requirements and the second set of demand requirements. The processor uses the demand compatibility rule to compute a demand type overlap value between the first demand type and the second demand type. In turn, the processor computes a minimum facility requirement based upon the demand type overlap value and generates a facility report that includes the minimum facility requirement. | 03-22-2012 |
Manesh Dixit, Sunrise, FL US
| Patent application number | Description | Published |
|---|---|---|
| 20090081286 | Extended release venlafaxine formulation - A controlled release dosage form of venlafaxine that comprises an immediate release pellet and an extended release pellet. | 03-26-2009 |
| 20110165234 | EXTENDED RELEASE VENLAFAXINE FORMULATION - A controlled release dosage form of venlafaxine that comprises an immediate release pellet and an extended release pellet. | 07-07-2011 |
| 20110268799 | ORAL CONTROLLED RELEASE DOSAGE FORM - A dosage form that provides a controlled release solid dosage form for the oral administration of a central nervous system stimulant, preferably methylphenidate hydrochloride. | 11-03-2011 |
Nagaraj Dixit, Gilbert, AZ US
| Patent application number | Description | Published |
|---|---|---|
| 20080231373 | Output Circuit - One embodiment of the invention provides an output circuit for a transistor. The output circuit includes a first capacitor coupled between ground and a drain electrode of the transistor via a first bond wire and a second bond wire coupling which couples a node between said first bond wire coupling and said first capacitor with ground via a second capacitor. | 09-25-2008 |
Nagaraj Dixit, Plainsboro, NJ US
| Patent application number | Description | Published |
|---|---|---|
| 20090047222 | Color Stable Peroxide Containing Dentifrice Formulations With Dye Encapsulated Silica Shell Nanoparticles - A composition for minimizing color fading of an oral care composition is provided. The composition comprises: a) an organic dye-encapsulated silica shell nanoparticle matrix, b) a physiologically stable fluoride ion providing compound in an amount of about 0.1% to about 1% by weight, c) a peroxide species providing compound in an amount of about 1% to to about 20% by weight. The encapsulated silica shell dye nanoparticle stabilizes the color against degradation in the presence of peroxide and fluoride ions. | 02-19-2009 |
Radhika Dixit, Westlake, OH US
| Patent application number | Description | Published |
|---|---|---|
| 20100214725 | PARALLEL PRINTED WIRING BOARD FOR LAMP ELECTRONIC ASSEMBLY AND BRACKET THEREFOR - A ballast assembly for a lamp includes a housing that receives a circuit board assembly therein. The circuit board assembly preferably has first and second board portions disposed in physically spaced, parallel relation. The board portions are interconnected by a conductive member, preferably a flexible conductive member. The spacing between the board portions is preferably substantially identical to a maximum height dimension of a tallest electrical component extending outwardly from one of the first and second board portions. A separate mounting bracket mechanically secures the housing to an associated surface and constrains the housing along at least one of first, second, and third perpendicular axes. Preferably, the mounting bracket is a one-piece construction where first and second ends of the bracket are laterally off-set, and the bracket can also serve as a heat sink to the ballast housing. | 08-26-2010 |
Ravindra Dixit, Ann Arbor, MI US
| Patent application number | Description | Published |
|---|---|---|
| 20100244447 | Continuously Variable Transmission Ratio Device with Optimized Primary Path Power Flow - A continuously variable transmission ratio device with optimized system efficiency by maximizing power flows through the primary power flow paths. The device is constructed from more than one fixed gear ratio device and controlled via a variator that is connected between the fixed gear ratio devices. The construction and operation of the continuously variable transmission ratio device is such that it provides a wide range of speed ratios between connected input and output devices and optimized system efficiency subject to constraints on the power flow through the variator. This continuously variable transmission ratio device can be used effectively in energy generation applications where optimized system efficiency entails coupling input and output devices with varying speed ratios for optimal component efficiency. | 09-30-2010 |
Sanjay G. Dixit, Southborough, MA US
| Patent application number | Description | Published |
|---|---|---|
| 20110010358 | PERFORMING SEQUENCE ANALYSIS AS A MULTIPART PLAN STORING INTERMEDIATE RESULTS AS A RELATION - A usage model and the underlying technology used to provide sequence analysis as part of a relational database system. Included components include the semantic and syntactic integration of the sequence analysis with an existing query language, the storage methods for the sequence data, and the design of a multipart execution scheme that runs the sequence analysis as part of a potentially larger database query, especially using parallel execution techniques. | 01-13-2011 |
Shailja Dixit, Waukesha, WI US
| Patent application number | Description | Published |
|---|---|---|
| 20100042429 | SYSTEM AND METHOD FOR PROVIDING LOCALLY ADAPTIVE DECISION SUPPORT - A system and method for providing adaptive decision support is disclosed in further detail herein. An embodiment of this system includes a local outcome report that documents a medical outcome, a difference engine that compares the local outcome report to a national outcome report and generates a localized rule, and a rule engine that receives patient data and applies the localized rule from the difference engine to the patient data to produce a prescribed treatment. An embodiment of the method disclosed herein begins with receiving local patient data and outcome data. The outcome data is compared to national outcome data and a local rule is generated from the comparison. Next, the local patient and the outcome data is analyzed and a standard rule is generated based upon this analysis. The standard rule and the local rule are then applied to the local patient data to generate a prescribed treatment. | 02-18-2010 |
| 20100081118 | System and Method for Prescribing Patient Education - A system and method for prescribing education is disclosed herein. The system includes an electronic medical record database, a user input device, a content source, and an education engine. The education engine receives a patient physiological condition from the electronic medical records database, patient information from the user input device, and selects medical education content from the content source in order to create a prescribed education plan. A method of treating a patient with prescribed education is also disclosed herein. The method includes the steps of obtaining a patient understanding level, obtaining a patient literacy level, and obtaining a patient physiological condition. The patient physiological condition and understanding level are used select medical education content for the patient education. The patient literacy level is used to select a media for the patient education. A prescribed education plan is created that comprises the selected medical education content and the selected media. | 04-01-2010 |
Suraj Dixit, Bloomington, IN US
| Patent application number | Description | Published |
|---|---|---|
| 20090104700 | METHODS FOR TRANSFERRING MOLECULAR SUBSTANCES INTO PLANT CELLS - Provided are methods for introducing a molecule of interest into a plant cell comprising a cell wall. Methods are provided for genetically or otherwise modifying plants and for treating or preventing disease in plant cells comprising a cell wall. | 04-23-2009 |
Vidula Dixit, Madison, AL US
| Patent application number | Description | Published |
|---|---|---|
| 20100280098 | RECEPTOR TARGETED OLIGONUCLEOTIDES - Disclosed herein are oligonucleotide conjugates that include ligands that target cell receptors that mediate endocytosis. The ligands can include peptides and small molecules. The conjugates can include carrier macromolecules to which the ligands and oligonucleotides are attached, or conjugates where an oligonucleotide is attached to a ligand in the absence of a carrier macromolecule. The oligonucleotides can include therapeutic oligonucleotides, such as siRNA, antisense RNA and miRNA. The ligand can be an RGD peptide. Also disclosed herein are methods of delivering the conjugates to cells in subjects. | 11-04-2010 |
Vidula R. Dixit, Madison, AL US
| Patent application number | Description | Published |
|---|---|---|
| 20120100096 | CONJUGATES PF SMALL-INTERFERING NUCLEIC ACIDS - The present invention relates to conjugates of small-interfering nucleic acids (siNA). Compositions of siNA suited for administration to a patient are described. Methods for delivering the compositions are also described. | 04-26-2012 |
Vishwa Deep Dixit, Baton Rouge, LA US
| Patent application number | Description | Published |
|---|---|---|
| 20080269116 | Methods of Inhibiting Proinflammatory Cytokine Expression Using Ghrelin - The present invention provides a method of inhibiting proinflammatory cytokine expression using ghrelin. | 10-30-2008 |
| 20110143992 | Methods and Compositions Related to GHS-R Antagonists - Disclosed herein are methods and compositions related to GHS-R antagonists. | 06-16-2011 |